Novo Secures EU Panel’s Backing for Cardiovascular Use of Wegovy

With Thursday’s positive opinion from the Committee for Medicinal Products for Human Use, the matter now heads to the European Commission which will have the final say on whether Wegovy’s label will be updated.

Scroll to Top